Sogelink (PRIVATE.SOGELINK)

Overall impact
A (82)

Commentary

Sogelink is a leader for overall positive impact. With an 'A' rating of 82.2 for overall impact (95th percentile compared to all companies), Sogelink ranks 31st out of 482 industry peers, behind Volue, Ellucian, Stratix and 27 others, and ahead of New Relic, Quhuo, Tricentis and 448 others. On top material causes for Sogelink's industry (Software), Sogelink performs well in Accountable Institutions (82.5 score), Accountable Institutions (82.5), Fair Labor Practices (81.8) and 49 other causes where it received an 'A' score. Sogelink did not receive a 'D' or 'F' rating on any cause.
Screens
Fur
Impact
Cause PRIVATE.SOGELINK
Peer rank
Overall impact

Log in to view this information

Screens
Fur
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2000
Employees
700
Sector
Information Technology
Industry
Software
Sub-industry
Application Software
SASB industry
Software & IT Services
Headquarters
France
Share classes
PRIVATE.SOGELINK
Description
Sogelink is a European Construction Tech software group serving infrastructure, construction and property-management professionals. It provides cloud, mobile and software tools that digitise work from project design through construction and asset operation. Its customers include civil engineers, surveyors, contractors, utility/network owners, engineering firms and public authorities. Its products support BIM and digital-twin workflows, topography, regulatory construction processes, infrastructure data and worksite safety. Examples include DICT.fr for excavation/regulatory declarations, software for road and infrastructure design, and Asbestos 360 risk-management tools. The group operates principally in France, the Netherlands, Norway and Hungary, with wider European and international activity.
Material causes
Ethos considers the following causes material for Sogelink, based on its industry sub-industry Application Software. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.